2 results

• Most Cancer Drugs Granted Accelerated Approval Later Show Few Real-World Benefits: Study

  April 10, 2024

  Martha Garcia

  A new study's findings reveal that many cancer drugs that go through the FDA's accelerated approval program end up not being safe, effective, or fully vetted before being granted full approval for use by patients.

• Study By Former FDA Advisors Finds Agency Is Biased Towards Approving New Drugs

  August 7, 2023

  Martha Garcia

  A new study warns that the FDA appears to have a bias toward approving new drugs, even when scientific advisors recommend against such approvals.